Literature DB >> 10666310

Evidence for requirement of NADPH-cytochrome P450 oxidoreductase in the microsomal NADPH-sterol Delta7-reductase system.

H Nishino1, T Ishibashi.   

Abstract

Rabbit antibodies raised against the hydrophilic part of microsomal NADPH-cytochrome P450 oxidoreductase (denoted fpT) demonstrated a marked ability to inhibit NADPH-sterol Delta7-reductase activity. In addition, trypsin and proteinase K treatment of microsomes removed almost all microsomal electron transfer constituents from the microsomes, but the Delta7-reductase activity could be reconstituted by adding detergent-solubilized NADPH-cytochrome P450 oxidoreductase (denoted OR). Furthermore, after solubilization from microsomes, the Delta7-reductase activity could be reconstituted with OR in a DEAE-cellulose column chromatography eluate fraction, which contained little OR activity. In the microsomal system, carbon monoxide, ketoconazole, and miconazole, specific inhibitors of cytochrome P450, had no effect on Delta7-reductase activity. These results provide the first evidence of an essential requirement of OR, which is distinct from cytochrome P450, in the NADPH-sterol Delta7-reductase system. EDTA, o-phenanthroline and KCN markedly lowered Delta7-reductase activity in a dose-dependent manner. Among metal ions tested, only ferric ion restored the reductase activity in the EDTA-treated microsomes. These results sugguest that NADPH-sterol Delta7-reductase is membrane-bound iron-dependent protein embedded in the microsomal lipid bilayer. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10666310     DOI: 10.1006/abbi.1999.1602

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  15 in total

1.  Electron transfer by human wild-type and A287P mutant P450 oxidoreductase assessed by transient kinetics: functional basis of P450 oxidoreductase deficiency.

Authors:  Yi Jin; Mo Chen; Trevor M Penning; Walter L Miller
Journal:  Biochem J       Date:  2015-05-15       Impact factor: 3.857

2.  Relationship between hepatic phenotype and changes in gene expression in cytochrome P450 reductase (POR) null mice.

Authors:  Xiu Jun Wang; Mark Chamberlain; Olga Vassieva; Colin J Henderson; C Roland Wolf
Journal:  Biochem J       Date:  2005-06-15       Impact factor: 3.857

3.  Human cytochrome P450 oxidoreductase deficiency caused by the Y181D mutation: molecular consequences and rescue of defect.

Authors:  Christopher C Marohnic; Satya P Panda; Karen McCammon; José Rueff; Bettie Sue Siler Masters; Michel Kranendonk
Journal:  Drug Metab Dispos       Date:  2009-11-02       Impact factor: 3.922

4.  cDNA Isolation and Expression of Nicotinamide Adenine Dinucleotide Phosphate-Dependent Cytochrome P450 Reductase Gene in the Chagas Disease Vector Triatoma infestans.

Authors:  Carla G Grosso; María M Stroppa; Gonzalo M Varela; Beatriz A García
Journal:  Am J Trop Med Hyg       Date:  2018-01-18       Impact factor: 2.345

Review 5.  From cholesterogenesis to steroidogenesis: role of riboflavin and flavoenzymes in the biosynthesis of vitamin D.

Authors:  John T Pinto; Arthur J L Cooper
Journal:  Adv Nutr       Date:  2014-03-01       Impact factor: 8.701

6.  7-Dehydrocholesterol reductase activity is independent of cytochrome P450 reductase.

Authors:  Ling Zou; Li Li; Todd D Porter
Journal:  J Steroid Biochem Mol Biol       Date:  2011-07-05       Impact factor: 4.292

7.  Mutations of human cytochrome P450 reductase differentially modulate heme oxygenase-1 activity and oligomerization.

Authors:  Christopher C Marohnic; Warren J Huber Iii; J Patrick Connick; James R Reed; Karen McCammon; Satya P Panda; Pavel Martásek; Wayne L Backes; Bettie Sue S Masters
Journal:  Arch Biochem Biophys       Date:  2011-06-28       Impact factor: 4.013

8.  Beta sheet 2-alpha helix C loop of cytochrome P450 reductase serves as a docking site for redox partners.

Authors:  Hyun-Hee Jang; Arvind P Jamakhandi; Shane Z Sullivan; Chul-Ho Yun; Paul F Hollenberg; Grover P Miller
Journal:  Biochim Biophys Acta       Date:  2010-02-10

Review 9.  Smith-Lemli-Opitz syndrome.

Authors:  Andrea E DeBarber; Yasemen Eroglu; Louise S Merkens; Anuradha S Pappu; Robert D Steiner
Journal:  Expert Rev Mol Med       Date:  2011-07-22       Impact factor: 5.600

10.  Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase.

Authors:  Vishal Agrawal; Ji Ha Choi; Kathleen M Giacomini; Walter L Miller
Journal:  Pharmacogenet Genomics       Date:  2010-10       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.